Results 21 to 30 of about 2,173,559 (359)

Facilitators and barriers of adaptation to diabetes: experiences of Iranian patients [PDF]

, 2014
Background: Diabetes mellitus is one of the most challenging and burdensome chronic diseases of the 21st century and More than 1% of the Iranian urban population older than 20 years develops Type 2 diabetes each year.
Arshadi Bostanabad, M., Jouybari, L., Karimi Moonaghi, H., McDonald, H., Namdar Areshtanab, H.   +4 more
core   +2 more sources

Metformin treatment for diabetes mellitus correlates with progression and survival in colorectal carcinoma [PDF]

, 2020
BACKGROUND: Diabetes mellitus is unfavorably associated with cancer risk. The purpose of this multi-disciplinary project was to evaluate a possible association of diabetes mellitus and other comorbidities and their treatment with progression of ...
Brown, Robert E., Cempírková, Dana, Dundr, Pavel, Gregorová, Jana, Grimmichová, Tereza, Heneberg, Petr, Janurová, Kateřina, Litschmannová, Martina, Pešta, Michal, Powell, Marta K., Třebický, Ferdinand   +10 more
core   +1 more source

Hypomagnesemia in type 2 diabetes mellitus

Indian Journal of Endocrinology and Metabolism, 2012
Introduction: Hypomagnesemia is reported in type 2 diabetes; magnesium deficiency may play a role in the development of endothelial dysfunction and altered insulin function.
Arundhati Dasgupta, Dipti Sarma, Uma Kaimal Saikia   +2 more
doaj   +1 more source

Identification of Micronuclei in the Lymphocytes of the Type 2 Diabetes Mellitus According to the Period of Diagnosis as a Biomarker

Polytechnic Journal, 2023
Micronuclei in lymphocytes can indicate DNA damage or chromosomal instability. This study aimed to compare the Micronuclei to the different period diagnoses of type 2 diabetes mellitus. Four groups were created out of 140 people: type 2 diabetes mellitus
Harem Othman Smail
doaj   +1 more source

Mapping the methylation status of the miR-145 promoter in saphenous vein smooth muscle cells from individuals with type 2 diabetes [PDF]

, 2016
Type 2 diabetes mellitus prevalence is growing globally, and the leading cause of mortality in these patients is cardiovascular disease. Epigenetic mechanisms such as microRNAs (miRs) and DNA methylation may contribute to complications of type 2 diabetes
Huntriss, J, Keeble, CM, O'Regan, DJ, Porter, KE, Riches, K, Turner, NA, Wood, IC   +6 more
core   +2 more sources

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.

New England Journal of Medicine, 2013
BACKGROUND The cardiovascular safety and efficacy of many current antihyperglycemic agents, including saxagliptin, a dipeptidyl peptidase 4 (DPP-4) inhibitor, are unclear.
B. Scirica, Deepak L. Bhatt, E. Braunwald, P. Steg, J. Davidson, B. Hirshberg, P. Ohman, R. Frederich, S. Wiviott, Elaine B. Hoffman, M. Cavender, J. Udell, N. Desai, Ofri Mosenzon, Darren K Mcguire, K. Ray, Lawrence A Leiter, I. Raz   +17 more
semanticscholar   +1 more source

A Narrative Review on Sarcopenia in Type 2 Diabetes Mellitus: Prevalence and Associated Factors

Nutrients, 2021
Type 2 diabetes mellitus (T2DM) represents a major health burden for the elderly population, affecting approximately 25% of people over the age of 65 years.
A. Izzo, E. Massimino, G. Riccardi, G. Della Pepa   +3 more
semanticscholar   +1 more source

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.

New England Journal of Medicine, 2019
BACKGROUND Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium-glucose cotransporter 2 (SGLT2), exploratory results have ...
V. Perkovic, M. Jardine, B. Neal, Severine Bompoint, H. Heerspink, D. Charytan, Robert Edwards, R. Agarwal, G. Bakris, S. Bull, C. Cannon, G. Capuano, P. Chu, D. de Zeeuw, T. Greene, A. Levin, C. Pollock, D. Wheeler, Yshai Yavin, Hong Zhang, B. Zinman, G. Meininger, B. Brenner, K. Mahaffey   +23 more
semanticscholar   +1 more source

Persistence of Risk for Type 2 Diabetes After Gestational Diabetes Mellitus

Diabetes Care, 2022
OBJECTIVE Gestational diabetes mellitus complicates ∼6% of pregnancies and strongly predicts subsequent type 2 diabetes. It has not been fully elucidated how risk depends on the number of affected pregnancies or how long the excess risk persists ...
Mary V Diaz-Santana, K. O’Brien, Y. Park, D. Sandler, C. Weinberg   +4 more
semanticscholar   +1 more source

Kidneys and Diabetes Mellitus Type 2

Počki, 2012
No ...
D.D. Ivanov
doaj   +1 more source